C.Q. PHARMACEUTICAC.Q. PHARMACEUTICAC.Q. PHARMACEUTICA

C.Q. PHARMACEUTICA

No trades
See on Supercharts
Market capitalization
‪10.21 B‬CNY
0.25CNY
‪654.96 M‬CNY
‪79.90 B‬CNY
‪595.19 M‬
Beta (1Y)
1.13
Employees (FY)
‪14.48 K‬
Change (1Y)
+676 +4.90%
Revenue / Employee (1Y)
‪776.94 K‬CNY
Net income / Employee (1Y)
‪6.37 K‬CNY

About C.Q. PHARMACEUTICA


CEO
Wei Liu
Headquarters
Chongqing
Website
Founded
1999
ISIN
CNE0000010K0
FIGI
BBG000GBLKH1
C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail business of pharmaceuticals and medical devices. Its products include chemical drugs, biopharmaceuticals, medical devices, and health products. The company was founded on May 28, 1999 and is headquartered in Chongqing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 000950 is 5.76 CNY — it has decreased by −1.86% in the past 24 hours. Watch C.Q. PHARMACEUTICA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange C.Q. PHARMACEUTICA stocks are traded under the ticker 000950.
000950 stock has risen by 2.47% compared to the previous week, the month change is a 10.48% rise, over the last year C.Q. PHARMACEUTICA has showed a 9.92% increase.
000950 reached its all-time high on May 29, 2015 with the price of 15.00 CNY, and its all-time low was 1.51 CNY and was reached on Jul 18, 2005. View more price dynamics on 000950 chart.
See other stocks reaching their highest and lowest prices.
000950 stock is 2.27% volatile and has beta coefficient of 1.13. Track C.Q. PHARMACEUTICA stock price on the chart and check out the list of the most volatile stocks — is C.Q. PHARMACEUTICA there?
Today C.Q. PHARMACEUTICA has the market capitalization of ‪10.21 B‬, it has increased by 2.69% over the last week.
Yes, you can track C.Q. PHARMACEUTICA financials in yearly and quarterly reports right on TradingView.
000950 net income for the last quarter is ‪54.14 M‬ CNY, while the quarter before that showed ‪135.13 M‬ CNY of net income which accounts for −59.94% change. Track more C.Q. PHARMACEUTICA financial stats to get the full picture.
C.Q. PHARMACEUTICA dividend yield was 1.01% in 2023, and payout ratio reached 13.19%. The year before the numbers were 1.18% and 10.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has ‪14.48 K‬ employees. See our rating of the largest employees — is C.Q. PHARMACEUTICA on this list?
Like other stocks, 000950 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade C.Q. PHARMACEUTICA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So C.Q. PHARMACEUTICA technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating C.Q. PHARMACEUTICA stock shows the buy signal. See more of C.Q. PHARMACEUTICA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.